News and Messages
BCRFA Announces Funding Opportunity for Collaborative Breast Cancer Research
Birmingham, Ala. — The Breast Cancer Research Foundation of Alabama (BCRFA) is currently accepting proposals for two-year collaborative breast cancer research awards among research entities within the state of Alabama.Projects may focus on any area of breast cancer research, which may include, but is not limited to: personalized medicine, prevention, early detection, drug discovery, immunotherapy, genomics and new breast cancer treatments.
Two grants will be awarded - one award is offered to a collaborative partnership with the UAB Comprehensive Cancer Center and another Alabama research entity, and a second award is being offered to a collaborative proposal between any two different research entities in Alabama. The approved projects will receive each $50,000 annually for two consecutive years, totaling $100,000 of support to each of the selected projects.
The Breast Cancer Research Foundation of Alabama is a nonprofit organization raising funding and awareness for breast cancer research in Alabama.
“Since the organization began in 1996, the BCRFA has invested over $7.7 million in breast cancer research initiatives in Alabama. This year, we are excited to be able to offer two awards supporting collaborative breast cancer research,” stated Beth Bradner Davis, BCRFA executive director. “Individual, corporate, and foundation support enable the BCRFA to fund one – or more – BCRFA Collaboration Awards each year.”
The goals for the Breast Cancer Research Foundation of Alabama Collaboration Award are as follows: to encourage collaborative research among top researchers in Alabama in the field of breast cancer research; to help support basic research which can be emerge into translational research; to offer financial support to promising breast cancer research in Alabama helping fund initial research so that the project can support future funding from national funders; and to offer hope to those affected by breast cancer and ultimately save lives through breast cancer research.
Last year’s BCRFA Collaboration Awards funded two collaborations. One award was for collaborators Dr. Gary Piazza of the University of South Alabama Mitchell Cancer Institute and Dr. Clinton Grubbs of the University of Alabama - Birmingham Comprehensive Cancer Center, researching “A Novel Wnt/β-Catenin Inhibitor for Breast Cancer,” which focuses on developing a promising experimental drug, MCI-030, for breast cancer prevention and treatment and further study its unique mechanism of action involving the suppression of Wnt/β-Catenin signaling.
The second award went to Drs. Joel Berry, Jessy Deshane and Andra Frost of UAB and Dr. Mark Suto of Southern Research Institute. Their project is “A Humanized 3D Immunocompetant Model of Breast Cancer for Precision Medicine and Immune Therapy Development” is developing a 3D humanized immunocompetent breast cancer model that will enhance cancer drug development and advance personalized cancer therapy.
Proposals must be submitted for consideration to the BCRFA by August 31. To request a copy of the submission guidelines and further details on the award, click here, or email BCRFA@uab.edu.